4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

Criteria for diagnosis of arrhythmogenic cardiomyopathy (ACM) were first proposed in 1994
and revised in 2010 by a Task Force. Although the Task Force criteria demonstrated a good …

Since the inception of the Canadian Cardiovascular Society heart failure (HF) guidelines in
2006, much has changed in the care for patients with HF. Over the past decade, the HF …

The original designation of “Arrhythmogenic right ventricular (dysplasia/) cardiomyopathy”(
ARVC) was used by the scientists who first discovered the disease, in the pre-genetic and …

Arrhythmogenic cardiomyopathy (AC) is a progressive disease with high risk of life-
threatening ventricular arrhythmias. A genetic mutation is found in up to 50–60% of …

Background The routine collection of large amounts of clinical data,'big data', is becoming
more common, as are research studies that make use of these data source. The aim of this …

Objectives: The aim of this study was to investigate the prognostic value of
echocardiographic deformation imaging in arrhythmogenic right ventricular cardiomyopathy …

Aims Arrhythmogenic right ventricular cardiomyopathy (ARVC) is diagnosed by a complex
set of clinical tests as per 2010 Task Force Criteria (TFC). Avoiding misdiagnosis is crucial to …

This review aims to give an update on the pathogenesis, clinical manifestations, and
diagnosis of arrhythmogenic right ventricular cardiomyopathy (ARVC). Arrhythmogenic right …

Background Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heritable heart
muscle disease that causes sudden cardiac death in the young. Inflammatory myocardial …